D-0750-2021 Class II Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Princeton, NJ

Recall Details

Product Type
Drugs
Report Date
August 25, 2021
Initiation Date
July 19, 2021
Termination Date
December 21, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
37560 bottles

Product Description

Tizanidine HCl Tablets, USP 4 mg, 150-count bottles, Rx only, Mfd By: Dr. Reddy's Laboratories limited, Srikakulam District, 532 409 INDIA, NDC 55111-180-15.

Reason for Recall

Failed Tablet/Capsule Specification: Some tablets are shaved

Distribution Pattern

Nationwide within the United States

Code Information

Lot #: T2000471, exp date 09/2023